Media Choice: Primary Care Portal

Media Choice: Primary Care Portal
Media Choice: Primary Care Portal

One of the most important parts of the office visit in my practice is patient education. When a patient understands their diagnosis, they become an active participant in their care, and as a result feel more empowered. Furthermore, when we as physicians properly educate our patients about their condition at the time of the visit, they are more likely to comply with our treatment. This is why at nearly every visit I print out patient handouts for my patients from the Primary Care Portal. This website developed by Dr. Mark Lees contains a plethora of evidence based clinical resources for the primary care physician and the specialist's online researching pleasure. While I primarily use the Patient Handouts portion of the site, the website also includes patient questionnaires, clinical and risk calculators, online journals, medical atlases, clinical skills sites, and pharmacology resources.  This website is the quick go-to guide for any physician.
Dr. Maiysha Clairborne is founder of Mind Body Spirit Wellness, Atlanta, GA

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.